# A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

> **NCT04150289** · — · COMPLETED · sponsor: **pharmaand GmbH** · enrollment: 248 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Farydak

## Key facts

- **NCT ID:** NCT04150289
- **Lead sponsor:** pharmaand GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2022-03-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150289, "A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04150289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*